{"id":41849,"date":"2023-11-20T01:55:22","date_gmt":"2023-11-20T07:55:22","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/ahod0831-pub\/"},"modified":"2023-11-20T01:55:22","modified_gmt":"2023-11-20T07:55:22","slug":"ahod0831-pub","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/ahod0831-pub\/","title":{"rendered":"AHOD0831-PUB"},"template":"","class_list":["post-41849","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p><span><span>Kelly, K. M., Cole, P. D., Pei, Q., Bush, R., Roberts, K. B., Hodgson, D. C., McCarten, K. M., Cho, S. Y., &amp; Schwartz, C. (2019). Response\u2010adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children\u2019s Oncology Group. In British Journal of Haematology (Vol. 187, Issue 1, pp. 39\u201348). Wiley.<\/span> <a href=\"https:\/\/doi.org\/10.1111\/bjh.16014\">https:\/\/doi.org\/10.1111\/bjh.16014<\/a><\/span><\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.1111\/bjh.16014","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/41849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=41849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}